Chemicalstructurebupren (Chemicalstructure1)
Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate Tablet
Product Images NDC 67296-2191
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate (NDC 67296-2191). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Chemicalstructurenal (Chemicalstructure2)
Containerlabel2mgpoint5mg (Containerlabel2mgpoint5mg)
This text provides information about the storage conditions for Buprenorphine and Naloxone sublingual tablets. It includes details about the manufacturing company, dosage, and precautions to prevent accidental ingestion by children. The tablets should be kept at a specific temperature range and stored in a secure location out of reach of children. The pharmacist is advised to dispense the accompanying medication guide to each patient along with the tablets. The text also lists the active ingredients in the tablets and recommends dispensing them in a light-resistant container with a child-resistant closure. Lastly, it mentions that the usual dosage information can be found in the product information.*
Containerlabel8mg2mg (Containerlabel8mg2mg)
This is a medication label for sublingual tablets containing Buprenorphine and Naloxone. The storage instructions indicate storing between 20° to 25°C. It is distributed by Accord Healthcare, Inc and manufactured by WES Pharma Inc. The tablets are used for controlled purposes and come in a container with a child-resistant closure. The medication guide should be dispensed to each patient by the pharmacist. Each tablet contains 8 mg of Buprenorphine hydrochloride USP and 2 mg of Naloxone hydrochloride dihydrate USP. In case children accidentally take these tablets, emergency medical care is necessary.*
Figure1 (Fig1)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
